Lisa Heather
BHF Intermediate Fellow and Associate Professor
My research revolves around metabolism and the heart – understanding why metabolism is important and what the consequences are when it goes wrong.
My passion for metabolism began during my undergraduate degree in Medical Biochemistry at the University of Surrey. I loved the way everything fitted together into this complex jigsaw, which in many ways resembled the London Underground map. And just like a public transport network, if something goes wrong with one enzyme or pathway, the whole system can either adapt or grind to a halt.
My doctoral research investigated the role of abnormal substrate metabolism in the development of cardiac hypertrophy. My subsequent post-doctoral research focused on the role of mitochondrial metabolism in cardiac disease progression.
In 2011 I was awarded a Diabetes UK RD Lawrence Fellowship, to study the role of hypoxia and metabolism in the type 2 diabetic heart. Heart disease is the leading cause of mortality in patients with type 2 diabetes, and patients have increased incidence of, and decreased recovery following myocardial infarction.
In 2018 I was awarded a British Heart Foundation Intermediate Fellowship, to study why fat accumulation in the type 2 diabetic heart is such a bad thing. We are studying what fats can do to the function of the cardiomyocyte, and how they might be signalling to activate deleterious processes. We have identified a number of novel signalling roles for fatty acids within the diabetic myocardium - regulating transcription factors, post-translational modifications and competitively inhibiting enzymes - that contribute to cardiomyocyte dysfunction at rest and in response to stress in type 2 diabetes.
Key publications
FoxO1-zDHHC4-CD36 S-Acylation Axis Drives Metabolic Dysfunction in Diabetes.
Journal article
Dennis KMJH. et al, (2025), Circ Res, 136, 1545 - 1560
Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology.
Journal article
Heather LC. et al, (2024), Diabetes, 73, 659 - 670
CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease.
Journal article
Glatz JFC. et al, (2024), Physiol Rev, 104, 727 - 764
ctivation of HIF1α Rescues the Hypoxic Response and Reverses Metabolic Dysfunction in the Diabetic Heart.
Journal article
Sousa Fialho MDL. et al, (2021), Diabetes, 70, 2518 - 2531
Diabetic mitochondria are resistant to palmitoyl CoA inhibition of respiration, which is detrimental during ischemia.
Journal article
Kerr M. et al, (2021), FASEB J, 35
Rescue of myocardial energetic dysfunction in diabetes through the correction of mitochondrial hyperacetylation by honokiol.
Journal article
Kerr M. et al, (2020), JCI Insight, 5
Fatty acids prevent Hypoxia-Inducible Factor 1α signalling through decreased succinate in diabetes
Journal article
Heather L. et al, (2018), JACC: Basic to Translational Science
Recent publications
The metabolic balancing act between fatty acid and glucose substrate use for optimal myocardial function: Key role for membrane substrate transporters.
Journal article
Glatz JFC. et al, (2026), Am J Physiol Heart Circ Physiol
Systems Biology and Functional Assessments of Human iPSC-Cardiomyocyte Models of Insulin Resistance Capture Key Hallmarks of Diabetic Cardiomyopathy.
Journal article
Carter RD. et al, (2025), Diabetes, 74, 1929 - 1945
Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets.
Journal article
Mericskay M. et al, (2025), Nat Rev Cardiol, 22, 704 - 727
Oxidative phosphorylation is required for cardiomyocyte re-differentiation and long-term fish heart regeneration.
Journal article
Lekkos K. et al, (2025), Nat Cardiovasc Res, 4, 1363 - 1380
FoxO1-zDHHC4-CD36 S-Acylation Axis Drives Metabolic Dysfunction in Diabetes.
Journal article
Dennis KMJH. et al, (2025), Circ Res, 136, 1545 - 1560
Targeting glucose metabolism with dichloroacetate (DCA) reduces zika virus replication in brain cortical progenitors at different stages of maturation.
Journal article
Gilbert-Jaramillo J. et al, (2024), Antiviral Res, 228
ICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure in rats.
Journal article
Choksey A. et al, (2024), J Mol Cell Cardiol, 191, 12 - 22
Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology.
Journal article
Heather LC. et al, (2024), Diabetes, 73, 659 - 670
CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease.
Journal article
Glatz JFC. et al, (2024), Physiol Rev, 104, 727 - 764
Compartmentalisation proteomics revealed endolysosomal protein network changes in a goat model of atrial fibrillation
Journal article
PLATT F., (2024), iScience
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities.
Journal article
Machado ND. et al, (2023), Br J Cancer, 129, 897 - 899
Cardiomyocyte tetrahydrobiopterin synthesis regulates fatty acid metabolism and susceptibility to ischaemia-reperfusion injury.
Journal article
Chu SM. et al, (2023), Exp Physiol, 108, 874 - 890
Post-translational palmitoylation of metabolic proteins.
Journal article
Dennis KMJH. and Heather LC., (2023), Front Physiol, 14
Cardiometabolic risk factors vary with age differently in females and males.
Journal article
Miller JJ. and Heather LC., (2022), Nat Cardiovasc Res, 1, 796 - 797
Guidelines on models of diabetic heart disease.
Journal article
Heather LC. et al, (2022), Am J Physiol Heart Circ Physiol, 323, H176 - H200
cute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents.
Journal article
Hazlehurst JM. et al, (2022), Metabol Open, 14
Human metabolism: pathways and clinical aspects
Journal article
Evans RD. and Heather LC., (2022), Surgery (United Kingdom), 40, 219 - 226
Unravelling the role of acidic organelles in Goat Atrial Fibrillation
Conference paper
Ayagama T. et al, (2022), ACTA PHYSIOLOGICA, 236, 931 - 933
Deletion of tetrahydrobiopterin synthesis in cardiomyocytes causes downregulation of fatty acid metabolism whilst protected against cardiac ischemia reperfusion injury
Conference paper
Chu S. et al, (2022), JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 173, S125 - S125
ctivation of HIF1α Rescues the Hypoxic Response and Reverses Metabolic Dysfunction in the Diabetic Heart.
Journal article
Sousa Fialho MDL. et al, (2021), Diabetes, 70, 2518 - 2531
Diabetic mitochondria are resistant to palmitoyl CoA inhibition of respiration, which is detrimental during ischemia.
Journal article
Kerr M. et al, (2021), FASEB J, 35
Physiological and pharmacological stimulation for in vitro maturation of substrate metabolism in human induced pluripotent stem cell-derived cardiomyocytes.
Journal article
CARR C. et al, (2021), Scientific Reports
L-Carnitine Stimulates In Vivo Carbohydrate Metabolism in the Type 1 Diabetic Heart as Demonstrated by Hyperpolarized MRI.
Journal article
Savic D. et al, (2021), Metabolites, 11
Peritransplant Cardiometabolic and Mitochondrial Function: The Missing Piece in Donor Heart Dysfunction and Graft Failure.
Journal article
Wells MA. et al, (2021), Transplantation, 105, 496 - 508
Hyperpolarized magnetic resonance shows that the antiischemic drug meldonium leads to increased flux through pyruvate dehydrogenase in vivo resulting in improved postischemic function in the diabetic heart
Journal article
SAVIC D. et al, (2021), NMR in Biomedicine
Early detection of doxorubicin-induced cardiotoxicity in rats by its cardiac metabolic signature assessed with hyperpolarized MRI
Journal article
Timm KN. et al, (2020), Communications Biology, 3
Rapid, $B_1$-insensitive, dual-band quasi-adiabatic saturation transfer with optimal control for complete quantification of myocardial ATP flux
Journal article
Miller JJ. et al, (2020), Magnetic Resonance in Medicine
Dimethyl-2-oxoglutarate improves redox balance and mitochondrial function in muscle pericytes of individuals with diabetes mellitus.
Journal article
Faulkner A. et al, (2020), Diabetologia, 63, 2205 - 2217
Rescue of myocardial energetic dysfunction in diabetes through the correction of mitochondrial hyperacetylation by honokiol.
Journal article
Kerr M. et al, (2020), JCI Insight, 5
Positioning Metabolism as a Central Player in the Diabetic Heart.
Journal article
Mereweather LJ. et al, (2020), J Lipid Atheroscler, 9, 92 - 109
PHARMACOLOGICALLY TARGETING HIF1A TO IMPROVE POST-ISCHEMIC FUNCTION OF THE TYPE 2 DIABETIC HEART
Conference paper
Fialho MDLS. et al, (2020), CARDIOVASCULAR DRUGS AND THERAPY, 34, 273 - 273
Correction: The long non-coding RNA Cerox1 is a post transcriptional regulator of mitochondrial complex I catalytic activity.
Journal article
Sirey TM. et al, (2019), Elife, 8
Human metabolism: pathways and clinical aspects
Journal article
Evans RD. and Heather LC., (2019), Surgery (United Kingdom), 37, 302 - 309
The long non-coding RNA Cerox1 is a post transcriptional regulator of mitochondrial complex I catalytic activity.
Journal article
Sirey TM. et al, (2019), Elife, 8
Hypoxia-inducible factor 1 signalling, metabolism and its therapeutic potential in cardiovascular disease.
Journal article
Sousa Fialho MDL. et al, (2019), Biochim Biophys Acta Mol Basis Dis, 1865, 831 - 843
ssessing the effect of hypoxia on cardiac metabolism using Hyperpolarized 13C magnetic resonance spectroscopy
Journal article
TYLER DAMIAN. et al, (2019), NMR in Biomedicine
Linking diabetic cardiovascular disease with non-alcoholic fatty liver disease through L-carnitine: A hyperpolarized MRS study
Conference paper
Savic D. et al, (2019), JOURNAL OF HEPATOLOGY, 70, E315 - E316
Bernard and Joan Marshall Awards at the autumn meeting of the British Society for Cardiovascular Research 2017
Journal article
Carr CA. et al, (2018), Heart
Fatty acids prevent Hypoxia-Inducible Factor 1α signalling through decreased succinate in diabetes
Journal article
Heather L. et al, (2018), JACC: Basic to Translational Science
TREATMENT WITH OLEIC ACID AND A PPARa AGONIST INCREASES FATTY ACID OXIDATION IN BEATING HUMAN INDUCIBLE PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES
Conference paper
Al-Siddiqi H. et al, (2018), HEART, 104, A13 - A13
Investigating real-time metabolic flux changes in a rat model of doxorubicin-induced cardiotoxicity using hyperpolarized 13C magnetic resonance spectroscopy
Conference paper
Timm KN. et al, (2018), JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 120, 34 - 34
EFFECTS OF CARNITINE SUPPLEMENTATION IN THE TYPE 1 DIABETIC HEART: AN IN VIVO HYPERPOLARIZED MRS STUDY
Conference paper
Savic D. et al, (2018), HEART, 104, A12 - A12
MITOCHONDRIA MUST CHOOSE BETWEEN RESISTANCE TO FATTY ACYL CoA REGULATION OR RAPID RESPIRATION IN THE TYPE 2 DIABETIC HEART
Conference paper
Kerr M. et al, (2018), HEART, 104, A12 - A13
PHARMACOLOGICAL STIMULATION OF HIF SIGNALLING AS A POTENTIAL TREATMENT APPROACH FOR THE TYPE 2 DIABETIC HEART
Conference paper
Fialho MDLS. et al, (2018), HEART, 104, A13 - A13
DEPLETION OF CARDIAC SUCCINATE MEDIATES IMPAIRED HYPOXIA-INDUCIBLE FACTOR 1A SIGNALLING BY LONG CHAIN FATTY ACIDS IN INSULIN RESISTANCE
Conference paper
Dodd MS. et al, (2018), HEART, 104, A11 - A11
DIABETES-INDUCED INNATE IMMUNE MEMORY DRIVES INFLAMMATION AND ATHEROSCLEROSIS, DESPITE RESTORATION OF NORMOGLYCAEMIA
Conference paper
Edgar L. et al, (2018), HEART, 104, A111 - A111
Impaired hypoxia-inducible factor (HIF) 1α signalling in Type 2 diabetes following myocardial infarction is due to increased fatty acids, and can be reversed pharmacologically to improve post-ischaemic recovery
Conference paper
Fialho MDLS. et al, (2018), DIABETIC MEDICINE, 35, 52 - 53
The 'Goldilocks zone' of fatty acid metabolism; to ensure that the relationship with cardiac function is just right.
Journal article
Kerr M. et al, (2017), Clinical science (London, England : 1979), 131, 2079 - 2094
Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia/reoxygenation.
Journal article
Mansor LS. et al, (2017), Cardiovascular Research
THE CARDIAC HEPCIDIN/FERROPORTIN AXIS IS ESSNTIAL FOR CARDIAC IRON HOMEOSTASIS AND FUNCTION
Other
Lakhal-Littleton S. et al, (2017), HEART, 103, A137 - A137
Mitochondrial Dysfunction Is a Common Feature of Injury in Donor Kidneys After Brain and Circulatory Death
Other
Lo Faro M. et al, (2017), AMERICAN JOURNAL OF TRANSPLANTATION, 17, 727 - 728
Temporal effects of streptozotocin (STZ) induced diabetes on cardiac metabolism and function using hyperpolarised 13C MRS and CINE MRI
Poster
Savic DS. et al, (2017), DIABETIC MEDICINE, 34, 50 - 50
Type 2 diabetic hearts are energetically defective, with dysfunctional mitochondria insensitive to regulation by fatty acids
Conference paper
Kerr M. et al, (2017), DIABETIC MEDICINE, 34, 25 - 25
Targeting hypoxia-inducible factor 1 (HIF-1) signalling in the Type 2 diabetic heart: dimethyloxaloylglycine (DMOG) improves functional recovery following ischaemia-reperfusion despite no change in glycolysis
Poster
Sousa Fialho MDL. et al, (2017), DIABETIC MEDICINE, 34, 49 - 49
n essential cell-autonomous role for hepcidin in cardiac iron homeostasis.
Journal article
Lakhal-Littleton S. et al, (2016), Elife, 5
Ethyl 2-(2,3-dihyroxybenzamido) Acetate Induces Hypoxia Induced Factor-related Metabolic Changes in Cardiosphere-Derived Cells for Myocardial Infarction Therapy
Conference paper
Schofield CJ. et al, (2016), Health and the Environment Journal, 7, 77 - 95
Simultaneous in vivo assessment of cardiac and hepatic metabolism in the diabetic rat using hyperpolarized MRS
Journal article
Tyler DJ., (2016), NMR in Biomedicine
ssessment of Metformin Induced Changes in Cardiac and Hepatic Redox State Using Hyperpolarized[1-13C]Pyruvate.
Journal article
Lewis AJ. et al, (2016), Diabetes
The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high energy phosphate metabolism
Journal article
Slingo M. et al, (2016), American journal of physiology. Heart and circulatory physiology, ajpheart.00912.2015 - ajpheart.00912.2015
Using an Integrated -Omics Approach to Identify Key Cellular Processes That Are Disturbed in the Kidney After Brain Death
Journal article
Akhtar MZ. et al, (2016), American Journal of Transplantation, 16, 1421 - 1440
On the pivotal role of PPARα in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury.
Journal article
Cole MA. et al, (2016), The FASEB Journal
Metabolic pathways and abnormalities
Journal article
Evans RD. and Heather LC., (2016), Surgery (United Kingdom), 34, 266 - 272
Regulation of the subcellular trafficking of CD36, a major determinant of cardiac fatty acid utilization.
Journal article
Glatz JF. et al, (2016), BBA: Molecular and Cell Biology of Lipids
Preconditioning of Cardiosphere-Derived Cells With Hypoxia or Prolyl-4-Hydroxylase Inhibitors Increases Stemness and Decreases Reliance on Oxidative Metabolism.
Journal article
Tan SC. et al, (2016), Cell Transplant, 25, 35 - 53
TYPE 2 DIABETIC HEARTS ARE ENERGETICALLY DEFECTIVE BOTH GLOBALLY AND AT THE LEVEL OF THE MITOCHONDRIA
Conference paper
Kerr M. et al, (2016), HEART, 102, A1 - A1
HIF ACTIVATOR DMOG IMPROVES FUNCTIONAL RECOVERY FOLLOWING ISCHAEMIA-REPERFUSION IN THE TYPE 2 DIABETIC HEART
Conference paper
Fialho MDLS. et al, (2016), HEART, 102, A4 - A5
NON-INVASIVE ASSESSMENT OF METFORMIN INDUCED CHANGES IN CARDIAC AND HEPATIC REDOX STATE USING HYPERPOLARIZED [1-13C] PYRUVATE
Conference paper
Lewis AJM. et al, (2016), HEART, 102, A14 - A14
EFFECT OF CARNITINE SUPPLEMENTATION ON CARDIAC FUNCTION AND METABOLISM ASSESSED USING CINE MRI AND HYPERPOLARIZED MRS
Conference paper
Savic D. et al, (2016), HEART, 102, A9 - A9
FATTY ACIDS IMPAIR HIF1α ACTIVATION AND SUPPRESS METABOLIC ADAPTATION TO HYPOXIA IN INSULIN RESISTANCE
Conference paper
Dodd MS. et al, (2016), HEART, 102, A3 - A4
Does diabetes affect hypoxic signalling and metabolic adaptation in the heart?
Conference paper
Dodd MS. et al, (2016), DIABETIC MEDICINE, 33, 44 - 45
Metabolic Dysregulation and Mitochondrial Dysfunction Are Key Features of Injury Profiles of Donor Kidneys After Brain Death.
Other
Lo Faro M. et al, (2016), AMERICAN JOURNAL OF TRANSPLANTATION, 16, 632 - 632
bnormal cardiac energetics and metabolic profile in the Type 2 diabetic heart: a metabolomics approach
Conference paper
Fialho MDLS. et al, (2016), DIABETIC MEDICINE, 33, 81 - 81
Increased oxidative metabolism following hypoxia in the type 2 diabetic heart, despite normal hypoxia signalling and metabolic adaptation.
Journal article
Heather L. et al, (2015), The Journal of Physiology
Increasing Pyruvate Dehydrogenase Flux as a Treatment for Diabetic Cardiomyopathy: A Combined 13C Hyperpolarized Magnetic Resonance and Echocardiography Study.
Journal article
Le Page LM. et al, (2015), Diabetes, 64, 2735 - 2743
Reversal of diastolic dysfunction in a diabetic rat model by metabolic modulation
Conference paper
Le Page LM. et al, (2015), DIABETIC MEDICINE, 32, 43 - 44
PHARMACOLOGICAL INHIBITION OF SARCOLEMMAL FATTY ACID UPTAKE PROVIDES A NOVEL MECHANISM TO IMPROVE METABOLISM AND FUNCTION IN THE TYPE 2 DIABETIC HEART
Conference paper
Fialho MLS. et al, (2015), HEART, 101, A1 - A1
Pharmacological inhibition of sarcolemmal fatty acid uptake provides a novel mechanism to improve metabolism in the Type 2 diabetic heart
Conference paper
Mansor LM. et al, (2015), DIABETIC MEDICINE, 32, 44 - 44
Dietary nitrate increases arginine availability and protects mitochondrial complex I and energetics in the hypoxic rat heart.
Journal article
Ashmore T. et al, (2014), J Physiol, 592, 4715 - 4731
Investigating mitochondrial metabolism in contracting HL-1 cardiomyocytes following hypoxia and pharmacological HIF activation identifies HIF-dependent and independent mechanisms of regulation.
Journal article
Ambrose LJA. et al, (2014), J Cardiovasc Pharmacol Ther, 19, 574 - 585
Impaired in vivo mitochondrial Krebs cycle activity after myocardial infarction assessed using hyperpolarized magnetic resonance spectroscopy.
Journal article
Dodd MS. et al, (2014), Circ Cardiovasc Imaging, 7, 895 - 904
Dietary nitrate increases arginine availability and protects mitochondrial complex I and energetics in the hypoxic rat heart
Journal article
Ashmore T. et al, (2014), Journal of Physiology, 592, 4715 - 4731
P667Impaired chronic hypoxic response in type 2 diabetic hearts is associated with inability to downregulate PPARa.
Conference paper
Mansor L. et al, (2014), Cardiovasc Res, 103 Suppl 1
Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin.
Journal article
Mansor LS. et al, (2013), Cardiovasc Diabetol, 12
Differential translocation of the fatty acid transporter, FAT/CD36, and the glucose transporter, GLUT4, coordinates changes in cardiac substrate metabolism during ischemia and reperfusion.
Journal article
Heather LC. et al, (2013), Circ Heart Fail, 6, 1058 - 1066
practical guide to metabolomic profiling as a discovery tool for human heart disease.
Journal article
Heather LC. et al, (2013), J Mol Cell Cardiol, 55, 2 - 11
CARDIAC CHARACTERISATION OF A NEW RAT MODEL OF TYPE 2 DIABETES
Conference paper
Mansor L. et al, (2013), HEART, 99
ssessment of real-time in vivo cardiac and hepatic glucose metabolism in the diabetic rat, using hyperpolarised 13C pyruvate
Conference paper
Le Page LM. et al, (2013), DIABETIC MEDICINE, 30, 42 - 42
Impaired metabolic and functional recovery of the type 2 diabetic heart following hypoxia
Conference paper
Mansor LS. et al, (2013), DIABETIC MEDICINE, 30, 40 - 41
CHRONIC HYPOXIA CAUSES NO CHANGE IN CARDIAC PYRUVATE DEHYDROGENASE FLUX IN THE CONTROL OR DIABETIC RAT: AN IN VIVO STUDY
Conference paper
Le Page L. et al, (2013), HEART, 99
IMPAIRED IN VIVO MITOCHONDRIAL KREBS CYCLE ACTIVITY FOLLOWING MYOCARDIAL INFARCTION ASSESSED USING HYPERPOLARIZED MAGNETIC RESONANCE SPECTROSCOPY
Conference paper
Dodd M. et al, (2013), HEART, 99, A118 - A118
Cardiac characterisation of a new rat model of type 2 diabetes
Conference paper
Mansor LS. et al, (2013), DIABETIC MEDICINE, 30, 63 - 64
IMPAIRED METABOLIC AND FUNCTIONAL ADAPTATION TO HYPOXIA IN THE TYPE 2 DIABETIC HEART
Conference paper
Mansor L. et al, (2013), HEART, 99
In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart.
Journal article
Dodd MS. et al, (2012), Cardiovasc Res, 95, 69 - 76
Metabolic adaptation to chronic hypoxia in cardiac mitochondria.
Journal article
Heather LC. et al, (2012), Basic Res Cardiol, 107
Determining the in vivo regulation of cardiac pyruvate dehydrogenase based on label flux from hyperpolarised [1-13C]pyruvate.
Journal article
Schroeder MA. et al, (2011), NMR Biomed, 24, 980 - 987
Normobaric hypoxia impairs human cardiac energetics.
Journal article
Holloway C. et al, (2011), FASEB J, 25, 3130 - 3135
Normobaric hypoxia impairs human cardiac energetics
Journal article
Holloway C. et al, (2011), FASEB Journal, 25, 3130 - 3135
Role of pyruvate dehydrogenase inhibition in the development of hypertrophy in the hyperthyroid rat heart: a combined magnetic resonance imaging and hyperpolarized magnetic resonance spectroscopy study.
Journal article
Atherton HJ. et al, (2011), Circulation, 123, 2552 - 2561
igh fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart.
Journal article
Cole MA. et al, (2011), Basic Res Cardiol, 106, 447 - 457
igh fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart
Journal article
Cole MA. et al, (2011), Basic Research in Cardiology, 106, 447 - 457
Metabolism, hypoxia and the diabetic heart.
Journal article
Heather LC. and Clarke K., (2011), J Mol Cell Cardiol, 50, 598 - 605
Metabolism, hypoxia and the diabetic heart
Journal article
Heather LC. and Clarke K., (2011), Journal of Molecular and Cellular Cardiology, 50, 598 - 605
Validation of the in vivo assessment of pyruvate dehydrogenase activity using hyperpolarised 13C MRS.
Journal article
Atherton HJ. et al, (2011), NMR Biomed, 24, 201 - 208
Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis.
Journal article
Heather LC. et al, (2011), PLoS One, 6
Mitochondrial uncoupling proteins and energetics in human heart and skeletal muscle
Conference paper
Johnson A. et al, (2011), ANAESTHESIA, 66, 69 - 69
USE OF PROLYL HYDROXYLASE INHIBITORS TO INDUCE HIF-RELATED METABOLIC CHANGES AND INCREASE C-KIT EXPRESSION IN CARDIOSPHERE-DERIVED CELLS
Conference paper
Tan SC. et al, (2011), HEART, 97, 13 - 14
Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism.
Journal article
O'Flaherty L. et al, (2010), Hum Mol Genet, 19, 3844 - 3851
Critical role of complex III in the early metabolic changes following myocardial infarction.
Journal article
Heather LC. et al, (2010), Cardiovasc Res, 85, 127 - 136
denosine monophosphate-activated protein kinase activation, substrate transporter translocation, and metabolism in the contracting hyperthyroid rat heart.
Journal article
Heather LC. et al, (2010), Endocrinology, 151, 422 - 431
PPARα is Essential for Cardiac Metabolic Adaptation to Chronic Hypoxia
Conference paper
Cole MA. et al, (2010), CIRCULATION, 122
HYPOXIC PRECONDITIONING OF CARDIOSPHERE-DERIVED CELLS TO INCREASE RETENTION IN THE INFARCTED HEART
Conference paper
Tan SC. et al, (2010), HEART, 96
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA IS ESSENTIAL FOR CARDIAC ADAPTATION TO CHRONIC HYPOXIA
Conference paper
Cole M. et al, (2010), HEART, 96
NORMOBARIC HYPOXIA IMPAIRS CARDIAC ENERGETICS IN NORMAL HUMAN VOLUNTEERS
Conference paper
Holloway C. et al, (2010), HEART, 96
INVESTIGATING METABOLIC FLUX IN THE HYPERTHYROID HEART USING HYPERPOLARISED MAGNETIC RESONANCE
Conference paper
Dodd M. et al, (2010), HEART, 96
Isoproterenol induces in vivo functional and metabolic abnormalities: similar to those found in the infarcted rat heart.
Journal article
Heather LC. et al, (2009), J Physiol Pharmacol, 60, 31 - 39
Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy.
Journal article
Schroeder MA. et al, (2009), FASEB J, 23, 2529 - 2538
In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance.
Journal article
Schroeder MA. et al, (2008), Proc Natl Acad Sci U S A, 105, 12051 - 12056
Opposite correlations of cardiac palmitate oxidation rates and plasma free fatty acids with ejection fractions in the infarcted rat heart
Conference paper
Catchpole AF. et al, (2008), CARDIOVASCULAR DRUGS AND THERAPY, 22, 154 - 154
Investigating Metabolic Flux in the Hyperthyroid Heart using Hyperpolarised Magnetic Resonance
Conference paper
Atherton HJ. et al, (2008), CIRCULATION, 118, S996 - S996
Use of Hyperpolarized Magnetic Resonance for Non-Invasive Observation of Metabolic Regulation
Conference paper
Schroeder MA. et al, (2008), CIRCULATION, 118, S444 - S444
Hyperthyroidism increases substrate metabolism in proportion to increased contractile function and hypertrophy in the rat heart
Conference paper
Heather LC. et al, (2008), CARDIOVASCULAR DRUGS AND THERAPY, 22, 135 - 136
Fatty acid transporters in the hypertrophied human heart: Differences between atria and ventricles
Conference paper
Heather LC. et al, (2008), CARDIOVASCULAR DRUGS AND THERAPY, 22, 153 - 153
Erythropoietin treatment normalises fatty acid oxidation, but not function, in the chronically infarcted rat heart
Conference paper
Cole M. et al, (2008), CARDIOVASCULAR DRUGS AND THERAPY, 22, 153 - 154
Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart.
Journal article
Heather LC. et al, (2006), Cardiovasc Res, 72, 430 - 437
Correlation between fatty acid transporter levels, palmitate oxidation rates and ejection fractions in the chronically infarcted rat heart
Conference paper
Heather LC. et al, (2006), CARDIOVASCULAR DRUGS AND THERAPY, 20, 409 - 409
Free fatty acids reduce efficiency in the hypertrophied rat heart
Conference paper
Cole MA. et al, (2005), JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 38, 1013 - 1014
PPARg activation reduces hypertrophy in the hyperthyroid RAT heart
Conference paper
Heather LC. et al, (2005), JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 38, 1027 - 1028
Mechanism of heart failure resulting from chronic β-adrenergic stimulation
Conference paper
Carr C. et al, (2004), JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 37, 258 - 258